Carus Bio
1 known investors
Carus Bio develops next-generation in vivo CAR-T therapeutics using an mRNA delivery platform technology for cell and gene therapy. The company focuses on treatments for patients in the biotech and cell-gene therapy field.
BiotechDeep TechHealthtech
Investors · 1
Frequently asked questions
- What does Carus Bio do?
- Carus Bio develops next-generation in vivo CAR-T therapeutics using an mRNA delivery platform technology for cell and gene therapy. The company focuses on treatments for patients in the biotech and cell-gene therapy field.
- Who are Carus Bio's investors?
- Carus Bio's investors include DAYLI Partners.